These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34270785)

  • 1. Efficacy of short-term intravenous clindamycin prior to oral clindamycin-rifampicin treatment in hidradenitis suppurativa: a retrospective case series.
    Nikolakis G; Kristandt A; Hauptmann M; Becker M; Zouboulis CC
    Br J Dermatol; 2021 Dec; 185(6):1270-1272. PubMed ID: 34270785
    [No Abstract]   [Full Text] [Related]  

  • 2. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
    Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
    J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation.
    Caposiena Caro RD; Molinelli E; Brisigotti V; Offidani A; Bianchi L
    Clin Exp Dermatol; 2021 Jan; 46(1):96-102. PubMed ID: 32683727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa.
    Mendonça CO; Griffiths CE
    Br J Dermatol; 2006 May; 154(5):977-8. PubMed ID: 16634904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa in patients of paediatric age: a pilot prospective study.
    Bettoli V; Toni G; Odorici G; Forconi R; Corazza M
    Br J Dermatol; 2021 Jul; 185(1):216-217. PubMed ID: 33544882
    [No Abstract]   [Full Text] [Related]  

  • 6. Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination.
    Join-Lambert O; Ribadeau-Dumas F; Jullien V; Kitzis MD; Jais JP; Coignard-Biehler H; Guet-Revillet H; Consigny PH; Delage M; Nassif X; Lortholary O; Nassif A
    Eur J Dermatol; 2014; 24(1):94-5. PubMed ID: 24445967
    [No Abstract]   [Full Text] [Related]  

  • 7. Clostridium difficile arising in a patient with hidradenitis suppurativa on clindamycin and rifampin.
    Bessaleli E; Scheinfeld N
    Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: can some factors influence the response to the treatment?
    Bettoli V; Zauli S; Virgili A
    G Ital Dermatol Venereol; 2016 Apr; 151(2):216-8. PubMed ID: 27068603
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients.
    Delaunay J; Villani AP; Guillem P; Tristan A; Boibieux A; Jullien D
    Br J Dermatol; 2018 Jan; 178(1):e15-e16. PubMed ID: 28626900
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
    van Straalen KR; Tzellos T; Guillem P; Benhadou F; Cuenca-Barrales C; Daxhelet M; Daoud M; Efthymiou O; Giamarellos-Bourboulis EJ; Jemec GBE; Katoulis AC; Koenig A; Lazaridou E; Marzano AV; Matusiak Ł; Molina-Leyva A; Moltrasio C; Pinter A; Potenza C; Romaní J; Saunte DM; Skroza N; Stergianou D; Szepietowski J; Trigoni A; Vilarrasa E; van der Zee HH
    J Am Acad Dermatol; 2021 Aug; 85(2):369-378. PubMed ID: 33484766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampicin and clindamycin for hidradenitis.
    Wall D; Kirby B
    J Am Acad Dermatol; 2011 Apr; 64(4):790. PubMed ID: 21414503
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up.
    Dessinioti C; Zisimou C; Tzanetakou V; Stratigos A; Antoniou C
    Clin Exp Dermatol; 2016 Dec; 41(8):852-857. PubMed ID: 27753139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of clindamycin and rifampicin combination therapy in hidradenitis suppurativa: a 6-month prospective study.
    Yao Y; Jørgensen AR; Ring HC; Thomsen SF
    Br J Dermatol; 2021 Mar; 184(3):552-553. PubMed ID: 33000461
    [No Abstract]   [Full Text] [Related]  

  • 14. Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes.
    Schneller-Pavelescu L; Vergara-de Caso E; Martorell A; Romaní J; Lázaro M; Vilarrasa E; Díaz-Ley B; Vázquez-Osorio I; Segura Palacios JM; Azaña JM; González-López MA; Cañueto J; Molina-Leyva A; Leiva-Salinas M; Navarro-Triviño FJ; Sánchez-Payá J; Pascual JC
    J Am Acad Dermatol; 2019 May; 80(5):1455-1457. PubMed ID: 30630028
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on "Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes".
    Marasca C; Masarà A; Annunziata MC; Fattore D; Fabbrocini G
    J Am Acad Dermatol; 2023 May; 88(5):e269. PubMed ID: 30872151
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to: "Comment on 'Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes'".
    Schneller-Pavelescu L; Vergara-de Caso E; Martorell A; Romaní J; Lázaro M; Vilarrasa E; Díaz-Ley B; Vázquez-Osorio I; Segura Palacios JM; Azaña JM; González-López MA; Cañueto J; Molina-Leyva A; Leiva-Salinas M; Navarro-Triviño FJ; Sánchez-Payá J; Pascual JC
    J Am Acad Dermatol; 2023 May; 88(5):e271-e272. PubMed ID: 30872153
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic.
    Albrecht J; Baine PA; Ladizinski B; Jemec GB; Bigby M
    Br J Dermatol; 2019 Apr; 180(4):749-755. PubMed ID: 30281779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study.
    Marasca C; Annunziata MC; Villani A; Volpe S; Marasca D; Fabbrocini G
    J Drugs Dermatol; 2019 May; 18(5):437-438. PubMed ID: 31141853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin alone may be enough: is it time to abandon the classic oral clindamycin-rifampicin combination for hidradenitis suppurativa?
    Albrecht J; Barbaric J; Nast A
    Br J Dermatol; 2019 Apr; 180(4):949-950. PubMed ID: 30430552
    [No Abstract]   [Full Text] [Related]  

  • 20. Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa.
    Aarts P; van Huijstee JC; van der Zee HH; van Straalen KR; Prens EP
    J Eur Acad Dermatol Venereol; 2024 May; 38(5):904-909. PubMed ID: 38112226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.